It’s no secret that artificial intelligence has the potential to fundamentally change our world. But how does this come to life in healthcare today? Join us as we discuss the transformative collaboration between NeoGenomics and ConcertAI, a union that leverages generative AI technology and real-world evidence to pioneer advancements in cancer patient care. We’ll discuss how these companies are setting new standards in integrating clinical data and biomarker insights to inform therapeutic strategies, clinical trial designs, and ultimately enhance patient outcomes.